Search
Therapy Shows Promise for Rare Leukemia in Children
- OPACC
- Jul 3, 2024
- 1 min read
Kinase inhibitor trametinib may spare patients from intensive treatments, such as stem cell transplant, for an aggressive form of blood cancer in small children.
Recent Posts
See AllA Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in...
Recent study results indicated that pediatric patients with acute lymphoblastic leukemia (ALL) were experiencing some motor skill impacts...
Comments